NCT05806580
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- NO.197， Ruijin Er Road Shanghai, Shanghai Municipality, China
Clinical trial condition
Relapsed or Refractory B-cell Lymphoma
Explore clinical trials studying Relapsed or Refractory B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Relapsed or Refractory B-cell Lymphoma trial results
Not Yet Recruiting
Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma
NCT07622784
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Sun yat-sen university cancer center Guangzhou, Guangdong, China
Not Yet Recruiting
Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
NCT06062641
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Ruijin Hospital Shanghai, Shanhai, China
Not Yet Recruiting
A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma
NCT05814848
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified